Market Scenario:
Ebstein’s anomaly is a rare congenital disease that occurs due to improper development of the tricuspid valve in the first eight weeks of fetal growth. This disorder occurs when the tricuspid valve that divides the two chambers of the right side of the heart does not form correctly.
The global Ebstein’s Anomaly market is driven by the increasing number of congenital heart diseases and growing population; growing market players has increased the scope of Ebstein’s Anomaly market. Technological advancements, owing to which new and advanced products are being launched in the market, is another factor propelling the growth of this market.
Ebstein’s anomaly may be due to many factors, including genetics and the environment. Children born in a family with a history of heart defects may be more likely to have Ebstein’s anomaly. The mother’s exposure to certain medications, such as lithium, can lead to Ebstein’s anomaly in the child.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5633
However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures may hinder the growth of this market.
The Global Ebstein’s Anomaly market is expected to grow at a CAGR of 9.0% during the forecast period.
Key Players
Some of the key players in fungal eye infection market are Ebstein’s Anomaly market are Abbott Vascular, Boston Scientific Corporation, Cordis Corporation, Edwards Lifesciences, Ge Healthcare, Gore Medical, Medtronic, Inc., Numed, Inc., Siemens Healthcare, St. Jude Medical, and Toshiba Corporation among others.
Segmentation
The global Ebstein’s Anomaly market is segmented on the basis of treatment, diagnosis and end users.
On the basis of diagnosis Ebstein’s Anomaly market is segmented into echocardiogram, electrocardiogram (ECG) chest x-ray, cardiac MRI, Holter monitor, pulse oximetry, exercise stress test, electrophysiology study, and cardiac catheterization.
On the basis of the treatment, the market is segmented medications and surgical treatment. Surgical Treatment is further segmented into tricuspid valve repair, tricuspid valve replacement, closure of the atrial septal defect, and maze procedure.
On the basis of end users, the market is segmented into hospitals & surgical centers, and specialty clinics.
Regional Analysis
North America Ebstein’s Anomaly market is rapidly growing in the American region. On a regional basis, the Americas is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing number of congenital disorders and growing population has increased the scope for the Ebstein’s Anomaly market in North America. According to CDC (Centre for Disease Control), it was estimated that about 1 million U.S. children and about 1.4 million U.S. adults were living with CHDs. Additionally, CHDs affect nearly 1% of―or about 40,000―births per year in the United States.
Europe is the second largest market and holds a healthy share in the global Ebstein’s Anomaly market. The European market is expected to grow steadily during the forecast period owing to the skilled professionals and availability of advanced and accessible treatment facilities. Additionally, wide research and development activities for the treatment of rare disease and increasing government funding boost the market growth.
Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases such as diabetes is the major driver for the market growth. India is the fastest growing region owing to the increasing population. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drives the market.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.
LIST OF TABLES
Table 1 Ebstein’s Anomaly Industry Synopsis, 2017-2023
Table 2 Global Ebstein’s Anomaly Market Estimates And Forecast, 2017-2023, (USD Million)
Table 3 Global Ebstein’s Anomaly Market By Region, 2017-2023, (USD Million)
Table 5 Global Ebstein’s Anomaly Market By Treatment, 2017-2023, (USD Million)
Table 6 Global Ebstein’s Anomaly Market By Diagnosis, 2017-2023, (USD Million)
Table 7 Global Ebstein’s Anomaly Market By End Users, 2017-2023, (USD Million)
Table 8 North America Ebstein’s Anomaly Market By Treatment, 2017-2023, (USD Million)
Table 9 North America Ebstein’s Anomaly Market By Daignosis, 2017-2023, (USD Million)
Table 10 North America Ebstein’s Anomaly Market By End Users, 2017-2023, (USD Million)
Table 11 US Ebstein’s Anomaly Market By Treatment, 2017-2023, (USD Million)
Table 12 US Ebstein’s Anomaly Market By Daignosis, 2017-2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Ebstein’s Anomaly Market
Figure 3 Segmentation Market Dynamics For Ebstein’s Anomaly Market
Figure 4 Global Ebstein’s Anomaly Market Share, By Treatment 2016
Figure 5 Global Ebstein’s Anomaly Market Share, By Diagnosis 2016
Figure 6 Global Ebstein’s Anomaly Market Share, By End Users, 2016
Figure 7 Global Ebstein’s Anomaly Market Share, By Region, 2016
Figure 8 North America Ebstein’s Anomaly Market Share, By Country, 2016
Figure 9 Europe Ebstein’s Anomaly Market Share, By Country, 2016
Figure 10 Asia Pacific Ebstein’s Anomaly Market Share, By Country, 2016
Figure 11 Middle East & Africa Ebstein’s Anomaly Market Share, By Country, 2016
Figure 12 Global Ebstein’s Anomaly Market: Company Share Analysis, 2016 (%)
Browse More Report Details @ https://www.marketresearchfuture.com/reports/ebstein-s-anomaly-market-5633
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com